Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin 2 receptors.

M Allouche1, Y Sahraoui, Y Augery-Bourget

  • 1Unité d'Oncogénèse Appliquée, INSERM U 268, Hôpital Paul Brousse, Villejuif, France.

Leukemia Research
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

STSM 2025 & 2nd African Medical Writing Congress.

La Tunisie medicale·2026
Same author

Genomic insights into antibiotic-resistant Vibrio species from clinical and coastal environmental sources in India.

Marine pollution bulletin·2025
Same author

Biofilm-forming bacteria associated with corals secrete melanin with UV-absorption properties.

World journal of microbiology & biotechnology·2024
Same author

2022 TUNISIAN NATIONAL CONGRESS OF MEDICINE ABSTRACTS.

La Tunisie medicale·2023
Same author

[Circadian and septadian variation in sudden cardiac death : Autopsy registry of the Tunisian North].

Annales de cardiologie et d'angeiologie·2023
Same author

Patterns of unintentional fatal drowning among children in North Tunisia : A 10-year study.

Revue d'epidemiologie et de sante publique·2022
Same journal

A multicenter real-world study of clinical outcomes in octogenarians and older patients with acute myeloid leukemia.

Leukemia research·2026
Same journal

FLAMSA versus FLAG-IDA as salvage therapy in adults with relapsed/refractory acute myeloid leukemia and acute lymphoblastic leukemia: A single-center real-world retrospective study.

Leukemia research·2026
Same journal

CD244 modulates bone marrow infiltrating CD8<sup>+</sup> T cells and serves as a prognostic and immunotherapeutic target in acute myeloid leukemia.

Leukemia research·2026
Same journal

Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitors.

Leukemia research·2026
Same journal

Real-world outcomes of plasmablastic lymphoma: Treatment approaches and survival outcomes in the PLASMABLAT-001 cohort.

Leukemia research·2026
Same journal

CRS and ICANS as class-level adverse event for CD20 ×CD3 bispecific T-cell engagers: A Bayesian analysis of a nationwide database.

Leukemia research·2026
See all related articles

Interleukin 2 receptors (IL-2-R) have alpha and beta chains, forming complexes with varying affinities. Only high and intermediate affinity IL-2-R are functional, mediating IL-2

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Interleukin 2 receptors (IL-2-R) are crucial for immune responses.
  • IL-2-R are composed of alpha (p55/Tac) and beta (p70/p75) chains.
  • These chains associate to form complexes with distinct IL-2 binding affinities.

Purpose of the Study:

  • To elucidate the functional roles of different Interleukin 2 receptor (IL-2-R) chain compositions.
  • To investigate the expression patterns of IL-2-R chains on various cell types.
  • To explore potential new functions of IL-2 beyond lymphoid cells.

Main Methods:

  • Characterization of IL-2 receptor binding affinities based on chain composition.
  • Analysis of IL-2 receptor chain expression on normal and leukemic cells.

Related Experiment Videos

  • Investigation of signal transduction mediated by different IL-2 receptor complexes.

    • Main Results:

    • High affinity IL-2-R (Kd 10-100 pM) require both alpha and beta chains.
    • Low (Kd 5-50 nM) and intermediate (Kd 1 nM) affinity IL-2-R are formed by alpha or beta chains alone, respectively.
    • The beta chain mediates IL-2 internalization and signal transduction, making only high and intermediate affinity IL-2-R functional.
    • High affinity IL-2-R are found on activated lymphoid cells; low affinity (Tac) on stimulated cells and monocytes; beta chain on resting cells and leukemic lineages.
    • IL-2-R expression was identified on non-lymphoid cells, suggesting novel IL-2 functions.

    Conclusions:

    • Functional IL-2-R require the beta chain for signal transduction.
    • Differential expression of IL-2-R chains on various cell types dictates IL-2 response.
    • The presence of IL-2-R on non-lymphoid cells opens new avenues for IL-2 research.